Screener
Dermata Therapeutics, Inc. DRMA Q2 2025 earnings
Reported August 13, 2025 · Before market open
EPS-$1.66Beat by $1.24
EPS estimate-$2.90
Next report
Nov 18, 2026 (in 3 months)Revenue estimate$25.0K
EPS estimate-$0.55
Versus estimates
Diluted EPS
FAQ
- When did Dermata Therapeutics, Inc. report Q2 2025 earnings?
- Dermata Therapeutics, Inc. (DRMA) reported Q2 2025 earnings on August 13, 2025 before market open.
- What were Dermata Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Dermata Therapeutics, Inc. reported eps of $-1.66 for Q2 2025.
- Did Dermata Therapeutics, Inc. beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-2.90 by $1.24.
- How did Dermata Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 60.3% from $-4.18.
- Where can I find Dermata Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001641172-25-023570) and the 10-Q periodic report (0001641172-25-023572) directly on SEC EDGAR. The filing index links above go to sec.gov.
